DK0382381T3 - Behandling af leukocyt-dysfunktion med GM-CSF - Google Patents
Behandling af leukocyt-dysfunktion med GM-CSFInfo
- Publication number
- DK0382381T3 DK0382381T3 DK90300840.7T DK90300840T DK0382381T3 DK 0382381 T3 DK0382381 T3 DK 0382381T3 DK 90300840 T DK90300840 T DK 90300840T DK 0382381 T3 DK0382381 T3 DK 0382381T3
- Authority
- DK
- Denmark
- Prior art keywords
- csf
- dysfunction
- treating
- treatment
- leukocyte
- Prior art date
Links
- 230000004064 dysfunction Effects 0.000 title abstract 5
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title abstract 4
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title abstract 4
- 210000000265 leukocyte Anatomy 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 208000014674 injury Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30439189A | 1989-01-30 | 1989-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0382381T3 true DK0382381T3 (da) | 1993-07-12 |
Family
ID=23176323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90300840.7T DK0382381T3 (da) | 1989-01-30 | 1990-01-26 | Behandling af leukocyt-dysfunktion med GM-CSF |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5178855A (fr) |
| EP (2) | EP0382381B1 (fr) |
| JP (1) | JPH0651640B2 (fr) |
| KR (1) | KR0137361B1 (fr) |
| AT (1) | ATE89737T1 (fr) |
| AU (1) | AU633054B2 (fr) |
| CA (1) | CA2045605C (fr) |
| DE (1) | DE69001686T2 (fr) |
| DK (1) | DK0382381T3 (fr) |
| ES (1) | ES2055314T3 (fr) |
| FI (1) | FI913625A0 (fr) |
| HK (1) | HK46196A (fr) |
| HU (1) | HU207229B (fr) |
| IE (1) | IE64234B1 (fr) |
| IL (1) | IL93219A (fr) |
| MY (1) | MY105798A (fr) |
| NZ (1) | NZ243953A (fr) |
| OA (1) | OA09509A (fr) |
| PT (1) | PT92995B (fr) |
| WO (1) | WO1990008554A1 (fr) |
| ZA (1) | ZA90600B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0526630A4 (en) * | 1991-02-22 | 1993-08-11 | Amgen Inc. | Use of gm-csf and g-csf to promote accelerated wound healing |
| GB9120304D0 (en) * | 1991-09-24 | 1991-11-06 | Erba Carlo Spa | Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor |
| EP0661057A4 (fr) * | 1993-06-08 | 1997-09-03 | Ajinomoto Kk | Accelerateur de la proliferation des cellules hematopietiques. |
| EP0791061A4 (fr) * | 1994-03-04 | 1998-07-15 | Ludwig Inst Cancer Res | Animaux a rupture genique ciblee |
| US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
| US6753165B1 (en) * | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
| US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
| US7153943B2 (en) * | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
| US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
| US6911204B2 (en) | 2000-08-11 | 2005-06-28 | Favrille, Inc. | Method and composition for altering a B cell mediated pathology |
| US20080171089A1 (en) * | 2006-12-22 | 2008-07-17 | Blondino Frank E | Stable anti-nausea oral spray formulations and methods |
| US7697268B2 (en) * | 2007-08-09 | 2010-04-13 | Haworth, Inc. | Modular electrical distribution system for a building |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5078996A (en) * | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| WO1987002060A1 (fr) * | 1985-10-03 | 1987-04-09 | Biogen N.V. | Polypeptides semblables aux facteurs de stimulation de colonies de granulocytes-macrophages (gm-csf) et leurs procedes de production en quantites importantes dans des cellules microbiennes |
| JPH0618778B2 (ja) * | 1985-10-04 | 1994-03-16 | 中外製薬株式会社 | 白血球減少症治療剤 |
| WO1987003204A1 (fr) * | 1985-11-27 | 1987-06-04 | Genetics Institute, Inc. | Traitement de maladies du type du sida |
| WO1987006954A1 (fr) * | 1986-05-06 | 1987-11-19 | Genetics Institute, Inc. | Production de m-csf |
| US5162111A (en) * | 1986-07-30 | 1992-11-10 | Grabstein Kenneth H | Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor |
| EP0276846A3 (fr) * | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Dérivés du facteur stimulant des colonies |
| EP0386109A1 (fr) * | 1987-11-12 | 1990-09-12 | Schering Corporation | Acceleration de formation osseuse a l'aide de gm-csf |
-
1990
- 1990-01-26 WO PCT/US1990/000379 patent/WO1990008554A1/fr not_active Application Discontinuation
- 1990-01-26 NZ NZ243953A patent/NZ243953A/en unknown
- 1990-01-26 EP EP90300840A patent/EP0382381B1/fr not_active Expired - Lifetime
- 1990-01-26 DK DK90300840.7T patent/DK0382381T3/da active
- 1990-01-26 KR KR1019900702160A patent/KR0137361B1/ko not_active IP Right Cessation
- 1990-01-26 CA CA002045605A patent/CA2045605C/fr not_active Expired - Fee Related
- 1990-01-26 MY MYPI90000141A patent/MY105798A/en unknown
- 1990-01-26 AU AU50488/90A patent/AU633054B2/en not_active Ceased
- 1990-01-26 HU HU901977A patent/HU207229B/hu not_active IP Right Cessation
- 1990-01-26 DE DE9090300840T patent/DE69001686T2/de not_active Expired - Fee Related
- 1990-01-26 US US07/721,586 patent/US5178855A/en not_active Expired - Fee Related
- 1990-01-26 AT AT90300840T patent/ATE89737T1/de not_active IP Right Cessation
- 1990-01-26 JP JP2503253A patent/JPH0651640B2/ja not_active Expired - Lifetime
- 1990-01-26 EP EP90903118A patent/EP0455726A1/fr active Pending
- 1990-01-26 ES ES90300840T patent/ES2055314T3/es not_active Expired - Lifetime
- 1990-01-26 ZA ZA90600A patent/ZA90600B/xx unknown
- 1990-01-29 IE IE31890A patent/IE64234B1/en not_active IP Right Cessation
- 1990-01-29 PT PT92995A patent/PT92995B/pt not_active IP Right Cessation
- 1990-01-30 IL IL9321990A patent/IL93219A/en not_active IP Right Cessation
-
1991
- 1991-07-23 OA OA60047A patent/OA09509A/en unknown
- 1991-07-30 FI FI913625A patent/FI913625A0/fi not_active Application Discontinuation
-
1996
- 1996-03-14 HK HK46196A patent/HK46196A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK46196A (en) | 1996-03-22 |
| ATE89737T1 (de) | 1993-06-15 |
| KR910700069A (ko) | 1991-03-13 |
| JPH0651640B2 (ja) | 1994-07-06 |
| NZ243953A (en) | 1997-06-24 |
| EP0382381B1 (fr) | 1993-05-26 |
| HUT57607A (en) | 1991-12-30 |
| KR0137361B1 (ko) | 1998-04-25 |
| DE69001686D1 (de) | 1993-07-01 |
| FI913625A0 (fi) | 1991-07-30 |
| IE900318L (en) | 1990-07-30 |
| AU633054B2 (en) | 1993-01-21 |
| IL93219A0 (en) | 1990-11-05 |
| HU207229B (en) | 1993-03-29 |
| EP0455726A1 (fr) | 1991-11-13 |
| DE69001686T2 (de) | 1993-09-02 |
| CA2045605C (fr) | 1997-02-11 |
| JPH03504980A (ja) | 1991-10-31 |
| WO1990008554A1 (fr) | 1990-08-09 |
| PT92995A (pt) | 1990-07-31 |
| MY105798A (en) | 1995-01-30 |
| IE64234B1 (en) | 1995-07-26 |
| US5178855A (en) | 1993-01-12 |
| IL93219A (en) | 1998-12-27 |
| OA09509A (en) | 1992-11-15 |
| CA2045605A1 (fr) | 1990-07-31 |
| AU5048890A (en) | 1990-08-24 |
| ES2055314T3 (es) | 1994-08-16 |
| ZA90600B (en) | 1990-10-31 |
| PT92995B (pt) | 1995-12-29 |
| EP0382381A1 (fr) | 1990-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
| BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
| HUT63564A (en) | Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine | |
| DK0382381T3 (da) | Behandling af leukocyt-dysfunktion med GM-CSF | |
| EP0317568A4 (fr) | Utilisation de stimulation de colonies de granulocytes-macrophage pour l'obtention d'un médicament pour le traitement de maladies bacteriènnes. | |
| KR890001580A (ko) | B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물 | |
| ATE481135T1 (de) | Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen | |
| KR870010871A (ko) | 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법 | |
| DE3750248D1 (de) | Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon. | |
| EP0397211A3 (fr) | Administration percutanée de la 3'-azido-3'-déoxythymidine | |
| KR900701311A (ko) | 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법 | |
| IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. |